Expanding chemical space of N-acyl sulfonamides for carbonic anhydrase inhibitor discovery
Oleksii V Gavrylenko1, Bohdan V Vashchenko2, Vasyl Naumchyk3
1Enamine Ltd.(1), Winston Churchill Street 78, Kyїv, 02094, Ukraine; V. P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry, NAS of Ukraine, Akademik Kukhar Street 1, Kyїv, 02066, Ukraine.
Abstract:
N-Acyl sulfonamides are widely recognized carboxylic acid isosteres that can fill the gap related to acidic compounds in chemical catalogs and bioactivity studies. This study presents the generation of synthetically tractable N-acyl sulfonamide chemical space based on the two-step parallel synthetic methodologies yielding structurally diverse compounds with high efficiency. Amide formation and SNAr combined with primary sulfonamide acylation proved to be highly effective in generating structurally diverse N-acyl sulfonamides with typically good synthesis success rates (up to 83 %) and average yields (up to 57 %). The approach demonstrated reliability across different substrates, supporting the efficient construction of a 526-member compound library (out of 3,258,356 possible combinations) with minor synthetic limitations. Biological evaluations of the synthesized library identified promising inhibitors of human carbonic anhydrase isoforms hCA-IX and hCA-II. Differential scanning fluorimetry screening and enzymatic assays revealed potent and selective compounds, with some derivatives exhibiting low micromolar IC50 values (i.e., N-((2-((2-(3-(dimethylamino)-1,2,4-oxadiazol-5-yl)ethyl)amino)thiazol-5-yl)sulfonyl)-2-(pyrrolidin-1-yl)isonicotinamide trifluoroacetate; hCA-IX IC50 = 1.2 μM; hCA-II IC50 = 6.7 μM) and selectivity toward hCA-IX (i.e., 3-chloro-N-((1-(5-(hydroxymethyl)-1,3,4-thiadiazol-2-yl)pyrrolidin-3-yl)sulfonyl)benzamide; hCA-IX IC50 = 11.5 μM; hCA-II IC50 = 192 μM). Several examples demonstrated moderate selectivity towards hCA-II, e.g. N-((5-(5-cyclobutyl-1,3,4-thiadiazol-2-yl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)sulfonyl)furan-2-carboxamide (hCA-IX IC50 = 32.8 μM; hCA-II IC50 = 4.4 μM) and N-((2-methyl-4-((1-(phenoxymethyl)cyclopropyl)carbamoyl)phenyl)sulfonyl)-1-(trifluoromethyl)-1H-pyrazole-4-carboxamide (hCA-IX IC50 = 46.3 μM; hCA-II IC50 = 5.5 μM). Molecular docking and molecular dynamics simulations provided further insights into binding interactions, confirming the stability of ligand-protein complexes. Thus, this work highlights the synthetic efficiency and pharmacological relevance of N-acyl sulfonamides, expanding the accessible chemical space for drug discovery.
Related Concept Videos
Amines to Sulfonamides: The Hinsberg Test
Generally, a primary amine reacts with the Hinsberg reagent to produce an N-substituted benzenesulfonamide. The electron-withdrawing sulfonyl...
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Preparation of Acid Anhydrides
The carboxylate ion acts as a nucleophile that attacks the carbonyl carbon of the acid chloride to form a tetrahedral intermediate. Subsequently, the re-formation of the carbonyl group with the loss of the chloride ion as a leaving group leads to the formation of an acid...
Preparation of Nitriles
Diazonium Group Substitution with Halogens and Cyanide: Sandmeyer and Schiemann Reactions
Electrophilic Aromatic Substitution: Sulfonation of Benzene


